Skip to main content
OrthoVellum
Knowledge Hub

Study

  • Topics
  • MCQs
  • ISAWE
  • Operative Surgery
  • Flashcards

Company

  • About Us
  • Editorial Policy
  • Contact
  • FAQ
  • Blog

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Medical Disclaimer
  • Copyright & DMCA
  • Refund Policy

Support

  • Help Center
  • Accessibility
  • Report an Issue
OrthoVellum

© 2026 OrthoVellum. For educational purposes only.

Not affiliated with the Royal Australasian College of Surgeons.

Limb Salvage Surgery Principles

Back to Topics
Contents
0%

Limb Salvage Surgery Principles

Comprehensive guide to limb salvage surgery principles for musculoskeletal tumours - Enneking staging, surgical margins, reconstruction options, endoprostheses, allografts, growing prostheses, rotationplasty, and functional outcomes for orthopaedic fellowship exam preparation

complete
Updated: 2025-01-08
High Yield Overview

LIMB SALVAGE SURGERY PRINCIPLES

Oncological Margins | Enneking Staging | Reconstruction Options | Functional Outcomes

85-90%Limb salvage rate for bone sarcomas
WideMinimum acceptable surgical margin
70-80%5-year prosthesis survival
MSTSFunctional outcome scoring system

SURGICAL MARGIN TYPES (ENNEKING)

Intralesional
PatternThrough tumour (curettage)
TreatmentContaminated - unacceptable for sarcoma
Marginal
PatternThrough reactive zone
TreatmentMicroscopic residual disease likely
Wide
PatternThrough normal tissue (cuff)
TreatmentMinimum acceptable for sarcoma
Radical
PatternEntire compartment removed
TreatmentRarely performed, maximum local control

Critical Must-Knows

  • Wide margin = minimum 2cm bone, cuff of normal tissue (fascia/muscle) for sarcoma
  • Enneking staging: Stage I = low grade, II = high grade, III = metastatic
  • Endoprosthesis = gold standard for periarticular reconstruction after tumour resection
  • Growing prostheses essential in paediatrics to address limb length inequality
  • Rotationplasty = biological alternative providing excellent function for distal femur tumours

Examiner's Pearls

  • "
    Local recurrence with intralesional/marginal margins approaches 50-100% for high-grade sarcoma
  • "
    Skip metastases occur in 1-5% - whole bone MRI essential before resection
  • "
    Allograft-prosthetic composite combines biological fixation with prosthetic joint
  • "
    Infection rate 10-15% for endoprostheses - higher than primary arthroplasty

Clinical Imaging

Imaging Gallery

Six-panel anteroposterior pelvic radiographic series demonstrating surgical treatment progression of pelvic osteosarcoma from initial presentation through post-treatment reconstruction
Click to expand
Six-panel anteroposterior pelvic radiographic series demonstrating surgical treatment progression of pelvic osteosarcoma from initial presentation thrCredit: Outcome of surgical treatment of pelvic osteosarcoma study via Open-i (NIH) via Open-i (NIH) (Open Access (CC BY))
Four-panel multimodality workflow: pre-op radiograph, MRI showing tumor extent, gross pathology specimen, post-op reconstruction radiograph with plate fixation
Click to expand
Four-panel multimodality workflow: pre-op radiograph, MRI showing tumor extent, gross pathology specimen, post-op reconstruction radiograph with plateCredit: Qu H et al. via World J Surg Oncol via Open-i (NIH) (Open Access (CC BY))
Six-panel follow-up series: serial radiographs showing fibula graft incorporation and hypertrophy (a-d), plus clinical photos demonstrating functional outcomes (e-f)
Click to expand
Six-panel follow-up series: serial radiographs showing fibula graft incorporation and hypertrophy (a-d), plus clinical photos demonstrating functionalCredit: Petersen MM et al. via Sarcoma via Open-i (NIH) (Open Access (CC BY))

Critical Limb Salvage Exam Points

Surgical Margins

Wide margin is minimum for sarcoma. Intralesional = curettage through tumour (contamination). Marginal = through reactive zone (microscopic disease). Wide = through normal tissue cuff (acceptable). Radical = entire compartment (rarely needed). Local recurrence correlates directly with margin adequacy.

Enneking Staging

Stage determines prognosis and treatment. Stage I = low grade (A intra, B extracompartmental). Stage II = high grade (A intra, B extracompartmental). Stage III = any grade with metastases. Surgical margins and adjuvant therapy guided by staging. Know benign staging too (1-3 latent to aggressive).

Reconstruction Options

Endoprosthesis is workhorse for periarticular reconstruction. Allograft provides biological stock but high complication rates. Autograft (vascularized fibula) for intercalary defects. Allograft-prosthetic composite combines benefits. Rotationplasty excellent function in young patients with distal femur tumours.

Complications

Infection 10-15% - higher than primary arthroplasty due to large dead space, adjuvant therapy effects. Aseptic loosening 5-10% at 10 years. Periprosthetic fracture 5-7%. Soft tissue failure (extensor mechanism, dislocation). Know Henderson classification for failure modes.

Reconstruction Option Selection Guide

Clinical ScenarioPreferred ReconstructionAlternativeKey Considerations
Distal femur osteosarcoma in adultModular endoprosthesisAllograft-prosthetic compositeMost common tumour site, reliable outcomes
Proximal tibia tumour in adolescentExtendible endoprosthesisRotationplastyMust address growth potential and extensor mechanism
Diaphyseal femur tumour (intercalary)Intercalary prosthesis or vascularized fibulaAllograft with platePreserve joints if possible, biological healing better
Distal femur in young child (under 8)RotationplastyExpandable prosthesisMultiple lengthening procedures vs single rotationplasty
Pelvis tumour (periacetabular)Custom hemipelvic prosthesisFlail hip (excision only)High complication rate, consider function vs survival
Failed limb salvage with infectionAmputationTwo-stage revision if bone stock allowsPatient safety paramount, functional amputation better than non-functional salvage
Mnemonic

MARGIN - Surgical Margin Principles

M
Measure preoperatively
MRI for tumour extent, CT for cortical involvement
A
Avoid reactive zone
Marginal margin goes through reactive zone - inadequate
R
Radical rarely needed
Whole compartment excision now uncommon
G
Goal is wide margin
2cm bone, cuff of normal tissue minimum
I
Intralesional is contamination
Curettage spreads tumour - only for benign lesions
N
Neurovascular bundle
Tumour encasement may preclude limb salvage

Memory Hook:The MARGIN you achieve determines local recurrence and survival

Mnemonic

SALVAGE - Limb Salvage Prerequisites

S
Staging complete
Local imaging plus chest CT for metastases
A
Adequate margin achievable
Can achieve wide margin without neurovascular sacrifice
L
Limb function preserved
Functional outcome must exceed amputation
V
Vascular supply intact
Major vessel reconstruction possible if needed
A
Adjuvant therapy planned
Neoadjuvant chemo for osteosarcoma, radiation for soft tissue
G
Growth potential addressed
Growing prosthesis or rotationplasty in children
E
Expectations realistic
Patient understands risks, complications, functional outcomes

Memory Hook:Check all SALVAGE criteria before proceeding - if any missing, consider amputation

Mnemonic

ENDO - Endoprosthesis Complications

E
Extensor mechanism failure
Proximal tibia - patellar tendon reattachment critical
N
Neurovascular injury
Peroneal nerve at risk in proximal tibia resection
D
Deep infection
10-15% rate, two-stage revision or amputation
O
Osseous loosening
Aseptic loosening 5-10% at 10 years

Memory Hook:ENDO complications are common - counsel patients about 30% reoperation rate at 10 years

Overview and Epidemiology

Definition

Limb salvage surgery is the surgical resection of a malignant bone or soft tissue tumour with reconstruction of the resultant defect, preserving a functional limb. The fundamental principle is achieving oncologically adequate surgical margins while maintaining limb function superior to amputation.

Evolution of Limb Salvage

Historically, amputation was the standard treatment for extremity sarcomas. The development of effective chemotherapy in the 1970s-80s, combined with advances in imaging (MRI) and reconstructive techniques (modular endoprostheses), revolutionized treatment. Limb salvage is now performed in 85-90% of bone sarcoma patients, with survival rates equivalent to amputation when adequate margins are achieved.

Epidemiology

Primary Bone Sarcomas:

  • Osteosarcoma: Most common primary bone malignancy, peak incidence 10-25 years
  • Ewing sarcoma: Second most common, peak 5-15 years
  • Chondrosarcoma: Third most common, peak 40-60 years
  • Combined incidence: 8-10 per million population annually

Common Sites Requiring Limb Salvage:

  • Distal femur (35-40% of osteosarcoma)
  • Proximal tibia (15-20%)
  • Proximal humerus (10-15%)
  • Proximal femur (10%)

Survival Equivalence

Limb salvage provides equivalent survival to amputation when adequate surgical margins are achieved. Multiple studies including the landmark Rougraff et al. series demonstrate no difference in overall survival or metastasis-free survival between limb salvage and amputation. The decision is therefore based on achieving adequate margins and functional outcome.

Indications for Limb Salvage

Absolute Requirements:

  • Adequate surgical margin achievable (wide or radical)
  • Reconstruction technically feasible
  • Preserved or reconstructible neurovascular structures
  • Expected function superior to amputation

Relative Contraindications:

  • Tumour encasing major neurovascular bundle
  • Pathological fracture with haematoma contamination
  • Extensive soft tissue extension precluding reconstruction
  • Skip metastases (may still salvage if all resectable)
  • Patient factors (age, comorbidities, expectations)

Pathophysiology and Tumour Biology

Tumour Growth and Spread

Understanding tumour behaviour is essential for surgical planning. Bone sarcomas exhibit characteristic patterns that inform margin requirements.

Local Extension:

  • Intramedullary spread: Osteosarcoma extends along medullary canal - MRI essential
  • Cortical breakthrough: Creates reactive zone and soft tissue mass
  • Skip metastases: Discontinuous intramedullary lesions in 1-5% of osteosarcoma
  • Joint involvement: Rare but occurs through cruciate ligament insertion, direct extension

Reactive Zone: The reactive zone surrounds the tumour pseudocapsule. It contains:

  • Compressed normal tissue
  • Inflammatory cells
  • Oedematous tissue
  • Microscopic tumour extension

Marginal margins go through the reactive zone and leave microscopic disease in 40-50% of cases for high-grade sarcoma. This results in local recurrence rates of 50-100%. Wide margin through normal tissue is the minimum acceptable standard.

Chemotherapy Effects

Neoadjuvant Chemotherapy for Osteosarcoma:

  • Standard of care - improves survival from 20% to 60-70%
  • Reduces tumour size, facilitates limb salvage
  • Creates necrosis - assessed at resection (Huvos grading)
  • Good response (greater than 90% necrosis): Better prognosis
  • Poor response: Consider adjuvant modification

Histological Response (Huvos Grading):

GradeNecrosisDescriptionPrognosis
I0-50%Little effectPoor
II51-89%Partial responseIntermediate
III90-99%Good responseGood
IV100%Complete responseExcellent

Wound Healing Considerations

Tumour surgery creates unique wound healing challenges:

  • Large dead space after resection
  • Chemotherapy impairs healing and immunity
  • Radiotherapy (soft tissue sarcoma) causes fibrosis
  • Metalwork and allografts are foreign bodies
  • Higher infection risk than routine arthroplasty

Classification and Staging

Enneking Surgical Staging System

The Enneking staging system is the most widely used classification for musculoskeletal tumours, guiding treatment and prognosis.

Enneking Staging for Malignant Tumours

StageGradeSiteMetastasesTreatment Approach
IALow (G1)Intracompartmental (T1)None (M0)Wide excision, consider adjuvants
IBLow (G1)Extracompartmental (T2)None (M0)Wide excision, margins critical
IIAHigh (G2)Intracompartmental (T1)None (M0)Neoadjuvant chemo, wide excision
IIBHigh (G2)Extracompartmental (T2)None (M0)Neoadjuvant chemo, wide excision
IIIAny gradeAny sitePresent (M1)Palliative or aggressive if isolated mets

Compartmental Definition:

  • Intracompartmental (T1): Confined within anatomical compartment (bone cortex intact)
  • Extracompartmental (T2): Extends beyond compartment (cortical breach, soft tissue extension)

Know the Benign Staging Too

Enneking Benign Tumour Staging:

  • Stage 1 (Latent): Static, asymptomatic (e.g., fibrous cortical defect)
  • Stage 2 (Active): Symptomatic, growing (e.g., aneurysmal bone cyst)
  • Stage 3 (Aggressive): Locally destructive (e.g., giant cell tumour)

Stage 3 benign may require margins similar to low-grade malignancy.

Surgical Margin Classification

The Enneking margin classification defines the plane of surgical dissection relative to the tumour.

Surgical Margin Types

Margin TypePlane of DissectionResidual DiseaseLocal Recurrence
IntralesionalWithin tumour substanceGross residual90-100%
MarginalThrough reactive zone/pseudocapsuleMicroscopic residual (40-50%)50-70%
WideThrough normal tissue (cuff around tumour)None if adequate5-10%
RadicalEntire compartment excisedNoneUnder 5%

Wide Margin Requirements:

  • Bone: Minimum 2cm from tumour extent on MRI
  • Soft tissue: Cuff of normal tissue (uninvolved fascia or muscle layer)
  • Neurovascular: Can include adventitia if not encased
  • Joint: Intra-articular resection if ligament involvement suspected

Planned vs Achieved Margin:

  • Planned margin is the surgical intent
  • Achieved margin is confirmed by pathology
  • Close margin (less than 1mm) requires MDT discussion - may need adjuvant radiotherapy

AJCC Staging (Alternative System)

The American Joint Committee on Cancer (AJCC) staging is used in some centres, particularly for soft tissue sarcoma.

Key Components:

  • T stage: Tumour size (T1 under 8cm, T2 over 8cm)
  • N stage: Regional lymph nodes (rare for sarcoma)
  • M stage: Distant metastases
  • G stage: Grade (1-3)

Comparison with Enneking:

  • AJCC more commonly used for soft tissue sarcoma
  • Enneking preferred for bone sarcoma
  • Both incorporate grade and extent
  • Enneking includes compartmental status (important surgically)

Clinical Presentation and Assessment

Presentation Patterns

Bone Sarcomas:

  • Pain: Progressive, worse at night, not relieved by rest
  • Swelling: Palpable mass in 50%
  • Pathological fracture: 5-10% present with fracture
  • Duration: Weeks to months

Red Flags for Malignancy:

  • Night pain
  • Progressive pain not responsive to simple analgesia
  • Mass increasing in size
  • Constitutional symptoms (weight loss, fatigue)
  • Age-size mismatch (large lesion in young patient)

Do not attribute bone pain in a young person to "growing pains" or sports injury without appropriate investigation. Delayed diagnosis of osteosarcoma remains common - average delay 3-4 months from symptom onset.

Clinical Examination

Inspection:

  • Mass location, size, skin changes
  • Muscle wasting
  • Limb length discrepancy
  • Angular deformity

Palpation:

  • Mass characteristics: Size, consistency, mobility, tenderness
  • Relation to underlying bone
  • Neurovascular status distally

Special Assessments:

  • Joint range of motion (adjacent joints)
  • Neurovascular examination (tumour may compress/invade)
  • Lymph node examination (unusual for bone sarcoma but check)

Staging Investigations

Local Staging:

  • Plain radiographs: First-line, may show characteristic features
  • MRI (whole bone): Essential - defines intramedullary extent, skip lesions, soft tissue mass
  • CT scan: Cortical involvement, matrix characterization

Systemic Staging:

  • CT chest: Lung metastases most common site
  • Bone scan or PET-CT: Skeletal metastases
  • Blood tests: LDH, ALP (prognostic markers)

Biopsy:

  • Essential for diagnosis before definitive surgery
  • Core needle biopsy preferred (less contamination than open)
  • Biopsy track must be excised with specimen
  • Perform at or communicate with treating centre

Whole Bone MRI

Always request whole bone MRI, not just the lesion. Skip metastases occur in 1-5% of osteosarcoma and change surgical planning. Missing a skip lesion and performing joint-sparing surgery would result in inadequate margins and local recurrence.

Multidisciplinary Team Assessment

Essential MDT Members:

  • Orthopaedic oncologist
  • Medical oncologist
  • Radiation oncologist
  • Musculoskeletal radiologist
  • Histopathologist
  • Specialist nurse

MDT Decisions:

  • Diagnosis confirmation
  • Staging determination
  • Neoadjuvant therapy plan
  • Surgical plan (salvage vs amputation)
  • Reconstruction choice
  • Follow-up protocol

Investigations

Investigation Protocol for Limb Salvage Planning

Step 1Plain Radiographs

Initial assessment:

  • AP and lateral of affected bone
  • Assess lesion location, size, matrix
  • Cortical involvement, periosteal reaction
  • Pathological fracture assessment

Classic Features:

  • Osteosarcoma: Sunburst periosteal reaction, Codman triangle
  • Ewing: Permeative "moth-eaten" destruction, onion-skin periosteal reaction
  • Chondrosarcoma: Rings-and-arcs calcification, endosteal scalloping
Step 2MRI - Essential for Planning

Whole bone with contrast:

  • T1, T2, STIR sequences
  • Gadolinium enhancement for soft tissue extent
  • Measure intramedullary extent for margin planning
  • Identify skip metastases (1-5%)
  • Assess joint involvement, neurovascular proximity

Key Measurements:

  • Distance from tumour to joint line
  • Intramedullary extent (for bone cut level)
  • Soft tissue mass dimensions
  • Proximity to neurovascular bundle
Step 3CT Scan

Complementary to MRI:

  • Cortical detail and matrix characterization
  • Staging CT chest (essential)
  • CT-guided biopsy if required
  • 3D reconstruction for complex anatomy (pelvis)
Step 4Nuclear Medicine

Whole body assessment:

  • Bone scan: Skeletal metastases
  • PET-CT: Increasingly used for staging and response assessment
  • PET may identify occult metastases
Step 5Tissue Diagnosis

Biopsy principles:

  • Core needle preferred over open (less contamination)
  • Biopsy track excised with specimen
  • Longitudinal approach, not transverse
  • Experienced pathologist essential
  • Frozen section at surgery to confirm diagnosis and margins

Biopsy Placement

The biopsy track is contaminated with tumour cells. Place the biopsy in line with the planned surgical incision so the track can be excised en bloc. Incorrectly placed biopsy may compromise limb salvage or require wider excision. In complex cases, perform biopsy at the treating centre.

Imaging Gallery

Complete surgical workflow from diagnosis to reconstruction for bone sarcoma
Click to expand
Four-panel multimodality imaging demonstrating complete limb salvage workflow. Panel A: Pre-operative radiograph showing lytic lesion in femoral diaphysis. Panel B: MRI T1-weighted sequence demonstrating intramedullary tumor extent with soft tissue component - essential for surgical margin planning. Panel C: Gross pathology specimen of resected tumor segment showing adequate margins. Panel D: Post-operative reconstruction radiographs with plate and screw fixation bridging segmental bone defect. Illustrates key principles: MRI defines resection margins, wide excision achieved, structural reconstruction restores bone continuity.Credit: Qu H et al. via World J Surg Oncol via Open-i (NIH) (Open Access (CC BY))
Vascularized fibula graft reconstruction outcomes with serial radiographic and clinical follow-up
Click to expand
Six-panel follow-up series demonstrating vascularized fibula graft reconstruction after bone sarcoma resection. Panels (a-d) show serial anteroposterior radiographs demonstrating progressive incorporation and hypertrophy of the vascularized fibula graft with plate fixation. Note consolidation at both proximal and distal host-graft junctions indicating successful biological incorporation. Panels (e-f) show clinical photographs demonstrating well-healed surgical scar and functional range of motion. Vascularized fibula grafts provide biological reconstruction for intercalary defects <15cm with union rates 80-90%, superior to non-vascularized grafts.Credit: Petersen MM et al. via Sarcoma via Open-i (NIH) (Open Access (CC BY))
Serial pelvic radiographs showing osteosarcoma treatment progression
Click to expand
Six-panel anteroposterior pelvic radiographic series (A-F) demonstrating surgical treatment progression of pelvic osteosarcoma. Sequential imaging shows evolution from initial tumor mass through neoadjuvant chemotherapy response to post-resection reconstruction. Pelvic sarcomas represent particularly challenging limb salvage scenarios due to anatomical constraints, difficulty achieving adequate margins, and complex reconstruction requirements. Serial imaging essential for monitoring chemotherapy response (tumor necrosis correlates with improved survival) and assessing reconstruction integrity over time.Credit: Outcome of surgical treatment of pelvic osteosarcoma study via Open-i (NIH) (Open Access (CC BY))

Management Principles

Preoperative Planning

Margin Determination:

  1. Review MRI with radiologist
  2. Measure intramedullary extent on MRI
  3. Add 2cm minimum to planned bone cut level
  4. Plan soft tissue cuff based on fascial planes
  5. Assess neurovascular involvement

Reconstruction Selection Factors:

  • Patient age and growth potential
  • Tumour location and resection extent
  • Expected functional demands
  • Available bone stock
  • Soft tissue coverage
  • Surgeon experience and resources

Prosthesis Planning:

  • Custom vs modular prosthesis
  • Sizing from imaging measurements
  • Stem length and fixation type
  • Joint constraint requirements

Bone Cut Level

Plan bone cut 2cm proximal to MRI-defined tumour extent. Add the distance from tumour edge to joint line to determine whether joint can be preserved (intercalary resection) or must be resected (articular resection). Joint preservation improves function when oncologically safe.

Chemotherapy for Osteosarcoma

Standard Protocol (MAP):

  • Methotrexate (high-dose with leucovorin rescue)
  • Adriamycin (doxorubicin)
  • Cisplatin (Platinum)

Timing:

  • 10-12 weeks neoadjuvant chemotherapy
  • Surgery after completion
  • Adjuvant chemotherapy continues post-operatively

Benefits:

  • Improves overall survival (20% to 65-70%)
  • Reduces tumour size (may enable limb salvage)
  • Treats micrometastatic disease
  • Assesses tumour response (prognostic)

Radiotherapy for Soft Tissue Sarcoma

Indications:

  • Adjunct to surgery for soft tissue sarcoma
  • Pre-operative (50Gy) or post-operative (60-66Gy)
  • Reduces local recurrence from 30% to 10-15%

Considerations for Bone:

  • Not standard for osteosarcoma (chemo-sensitive)
  • Consider for Ewing sarcoma (radiosensitive)
  • Consider for close margins if re-excision not possible

Selection Criteria

Limb Salvage Appropriate When:

  • Wide margin achievable
  • Major neurovascular bundle not encased
  • Adequate soft tissue for coverage
  • Functional outcome expected to exceed amputation
  • Patient understands and accepts risks/complications
  • Appropriate reconstruction available

Relative Indications for Amputation:

  • Neurovascular encasement requiring sacrifice
  • Pathological fracture with haematoma contamination
  • Extensive skip metastases
  • Infection compromising reconstruction
  • Patient preference
  • Functional outcome of salvage worse than amputation

Limb Salvage vs Amputation Decision

FactorFavours Limb SalvageFavours Amputation
Tumour extentAdequate margins achievableNeurovascular encasement
Pathological fractureNo haematoma spread, margins feasibleExtensive haematoma contamination
AgeAll ages (growing prosthesis for children)Very young child with extensive resection
Expected functionGood functional outcome expectedFlail, insensate, or painful limb expected
Patient factorsAccepts risks, realistic expectationsPrefers definitive procedure, active lifestyle needs

Surgical Technique - Reconstruction Options

Modular Endoprosthetic Reconstruction

Indications:

  • Periarticular tumours (most common reconstruction)
  • Distal femur, proximal tibia, proximal femur, proximal humerus
  • Immediate stability and early mobilization required

Advantages:

  • Immediate stability and weight bearing
  • No donor site morbidity
  • Predictable outcomes
  • Modular systems allow customization

Disadvantages:

  • Mechanical complications (loosening, breakage)
  • Infection rate 10-15%
  • Limited lifespan (70-80% survival at 10 years)
  • Multiple revisions likely in young patients

Surgical Technique - Distal Femur

Steps:

  1. Incision: Extensile anterior or medial approach, excise biopsy track
  2. Tumour resection: Wide margin including cuff of normal muscle
  3. Bone cut: 2cm proximal to MRI-defined tumour extent
  4. Canal preparation: Ream to accept cemented or press-fit stem
  5. Prosthesis assembly: Modular system allows length adjustment
  6. Soft tissue reconstruction: Medial gastrocnemius flap for coverage
  7. Extensor mechanism: Suture quadriceps to prosthesis if needed
  8. Closure: Layered closure over drain

Technical Pearls:

  • Avoid stripping soft tissue beyond resection margins
  • Gastrocnemius flap essential for proximal tibia coverage
  • Constrained hinge for most tumour prostheses
  • Hydroxyapatite collars may improve soft tissue attachment

Osteoarticular Allograft

Indications:

  • Joint replacement with biological articular surface
  • Rarely used now due to high complication rates

Outcomes:

  • Cartilage degeneration universal at 10 years
  • Fracture rate 20-25%
  • Nonunion rate 15-20%
  • Infection rate similar to endoprosthesis

Intercalary Allograft

Indications:

  • Diaphyseal defects where joints can be preserved
  • Combined with internal fixation (plate or nail)

Advantages:

  • Biological reconstruction
  • Potential for incorporation
  • Preserves both adjacent joints

Disadvantages:

  • Nonunion 15-25%
  • Fracture 15-20%
  • Prolonged healing time
  • Protected weight bearing 6-12 months

Allograft-Prosthetic Composite (APC)

Indications:

  • Combines biological bone stock with prosthetic joint
  • Soft tissue attachment to allograft
  • Particularly useful for proximal femur and humerus

Technique:

  • Prosthesis cemented into allograft off-table
  • Composite implanted and fixed to host bone
  • Tendon attachments sutured to allograft

Advantages:

  • Better soft tissue attachment than prosthesis alone
  • Bone stock for future revision
  • May reduce dislocation (greater trochanter attachment)

Vascularized Fibular Graft

Indications:

  • Intercalary defects (preserving both joints)
  • Combined with allograft (dual-strut technique)
  • Paediatric patients (growth potential)

Advantages:

  • Living bone with blood supply
  • Remodels and hypertrophies
  • Growth potential in children
  • Low infection risk

Disadvantages:

  • Technically demanding microsurgery
  • Prolonged protection (hypertrophy takes 1-2 years)
  • Fibula size mismatch for large defects
  • Donor site morbidity

Technique:

  • Peroneal artery pedicled or free vascularized graft
  • Inset into medullary canal or alongside allograft
  • Anastomosis to local vessels
  • Combined with plate or external fixation

Distraction Osteogenesis

Indications:

  • Intercalary defects, particularly in children
  • Alternative to bone transport

Technique:

  • Ring fixator application
  • Corticotomy at appropriate level
  • Gradual lengthening (1mm/day)
  • Prolonged treatment (months)

Expandable Endoprostheses

Indications:

  • Skeletally immature patients with periarticular tumours
  • Expected limb length discrepancy greater than 2-3cm

Types:

Non-Invasive Expandable:

  • External electromagnetic lengthening
  • No additional surgery for lengthening
  • Lengthening in clinic or radiology
  • Examples: STANMORE, Repiphysis systems

Minimally Invasive:

  • Small incision to access lengthening mechanism
  • Less surgery than traditional types

Traditional (Modular Replacement):

  • Requires surgery for each lengthening
  • Higher complication rate

Outcomes:

  • 15-20 lengthening procedures may be needed
  • Each procedure carries complication risk
  • Overall complication rate 50-70% over childhood
  • Failure modes: infection, fracture, mechanism failure

Growing Prosthesis Considerations

Growing prostheses require multiple procedures throughout childhood. Modern non-invasive expanding prostheses reduce but do not eliminate intervention. Consider rotationplasty as alternative - single procedure with excellent function, but significant body image concerns. Discuss both options thoroughly with family.

Van Nes Rotationplasty

Concept:

  • Resect tumour-bearing segment (distal femur/proximal tibia)
  • Rotate remaining distal limb 180 degrees
  • Ankle joint functions as "knee" joint
  • Foot faces posteriorly, fits into prosthesis

Indications:

  • Distal femur or proximal tibia tumour in children
  • Alternative to above-knee amputation
  • Alternative to multiple growing prosthesis procedures

Advantages:

  • Biological reconstruction (living tissue)
  • Ankle provides powered "knee" joint
  • Excellent functional outcomes
  • Single definitive procedure
  • No implant-related complications
  • Growth potential preserved

Disadvantages:

  • Cosmetic appearance (backward foot)
  • Psychological adjustment required
  • Requires highly motivated patient and family
  • Not universally accepted culturally

Functional Outcomes:

  • Superior function to above-knee amputation
  • Equivalent or better than tumour prosthesis in young patients
  • Return to high-level activities including sports
  • MSTS scores typically 80-90%

Rotationplasty provides excellent function but requires careful patient selection. The cosmetic appearance of the reversed foot can be challenging for some patients, particularly adolescents. However, many patients prefer the functional advantages over limb salvage complications or amputation limitations.

Complications

Henderson Classification of Endoprosthetic Failure

Type 1 - Soft Tissue Failure:

  • 1A: Wound dehiscence, flap necrosis
  • 1B: Aseptic instability (dislocation, tendon rupture)
  • Most common: Extensor mechanism failure (proximal tibia)

Type 2 - Aseptic Loosening:

  • Progressive loosening at bone-prosthesis interface
  • 5-10% at 10 years
  • Presents with pain, radiographic lucency
  • May require stem revision

Type 3 - Structural Failure:

  • 3A: Periprosthetic fracture
  • 3B: Implant fracture (stem, body, hinge)
  • Risk increases with time and activity level

Type 4 - Infection:

  • Deep periprosthetic infection
  • 10-15% overall (much higher than primary arthroplasty)
  • Often requires two-stage revision or amputation

Type 5 - Tumour Progression:

  • Local recurrence at resection margins
  • Requires re-resection or amputation

Henderson Classification Summary

TypeCategoryIncidenceManagement
Type 1AWound dehiscence/flap failure5-10%Soft tissue coverage, flap reconstruction
Type 1BInstability/tendon failure10-15% (prox tibia)Constraint revision, tendon reconstruction
Type 2Aseptic loosening5-10% at 10 yearsStem revision
Type 3Structural failure5-7%Fracture fixation or component exchange
Type 4Infection10-15%Two-stage revision or amputation
Type 5Tumour progression5-10%Re-resection or amputation

Periprosthetic Infection

Incidence:

  • 10-15% for tumour endoprostheses
  • Much higher than primary arthroplasty (1-2%)

Risk Factors:

  • Large dead space after resection
  • Chemotherapy-induced immunosuppression
  • Radiotherapy effects on soft tissue
  • Prolonged surgery
  • Poor soft tissue coverage

Presentation:

  • Acute: Wound breakdown, fever, sepsis
  • Chronic: Persistent pain, sinus formation

Management:

  • DAIR (Debridement, Antibiotics, Implant Retention): Early infection, stable implant
  • Two-stage revision: Chronic infection with biofilm
  • Amputation: Failed two-stage, uncontrollable sepsis

Infection in oncological prostheses is devastating. Two-stage revision has 60-70% success rate. Amputation required in 20-30% of infected tumour prostheses. Prevention (meticulous technique, prophylaxis, good soft tissue coverage) is crucial.

Mechanical Complications

Periprosthetic Fracture:

  • 5-7% incidence
  • Risk factors: Stress risers, poor bone quality, trauma
  • Management: ORIF, stem revision if loose

Aseptic Loosening:

  • 5-10% at 10 years
  • Press-fit stems may loosen earlier
  • Cemented stems more predictable initially
  • Presents with activity-related pain

Implant Breakage:

  • Hinge mechanism, stem, modular junctions
  • Improved with modern designs
  • May present with sudden instability

Soft Tissue Complications

Extensor Mechanism Failure:

  • Particularly proximal tibia resection
  • Patellar tendon requires reattachment to prosthesis
  • Failure rate 10-20% at 10 years
  • Consider gastrocnemius rotational flap

Hip Dislocation:

  • Proximal femur resection
  • Reduced by greater trochanter reconstruction (APC)
  • Constrained liner if recurrent

Local Recurrence

Incidence:

  • Wide margins: 5-10%
  • Marginal/contaminated margins: 50-70%

Management:

  • Re-staging (local and distant)
  • Re-resection if feasible
  • Amputation if margins cannot be achieved
  • Palliation if metastatic

Evidence Base

Limb Salvage vs Amputation Survival

Level III
Key Findings:
  • No significant difference in overall survival between limb salvage and amputation
  • Local recurrence rates equivalent with adequate margins
  • Metastasis-free survival similar between groups
  • Decision should be based on margin achievement and function
Clinical Implication: Limb salvage does not compromise survival when adequate margins are achieved. Amputation offers no survival advantage if margins are equivalent.
Source: Rougraff et al. JBJS Am 1994; Meta-analyses

Endoprosthesis Long-term Survival

Level III
Key Findings:
  • 10-year prosthesis survival 70-80%
  • 15-year survival 50-60%
  • Infection rate 10-15% overall
  • 30% reoperation rate at 10 years for any cause
Clinical Implication: Endoprostheses are durable but have higher complication rates than primary arthroplasty. Multiple procedures likely over patient's lifetime.
Source: Jeys et al. JBJS Br 2008; Systematic reviews

Rotationplasty Functional Outcomes

Level III
Key Findings:
  • MSTS functional scores 80-90% (excellent)
  • Superior function to above-knee amputation
  • Equivalent or superior to endoprosthesis in young patients
  • Psychological acceptance high in appropriately selected patients
Clinical Implication: Rotationplasty provides excellent function and should be discussed as an option for distal femur/proximal tibia tumours in children.
Source: Hillmann et al. JBJS Am 2000; Multiple series

Growing Prosthesis Complications

Level III
Key Findings:
  • Overall complication rate 50-70% during childhood
  • 15-20 lengthening procedures needed on average
  • Non-invasive systems reduce but do not eliminate interventions
  • Revision for mechanical failure, infection, loosening common
Clinical Implication: Growing prostheses require multiple procedures with significant complication burden. Rotationplasty offers single-procedure alternative.
Source: Groundland et al. Clin Orthop 2019; Systematic reviews

Exam Viva Scenarios

Practice these scenarios to excel in your viva examination

VIVA SCENARIOStandard

Distal Femur Osteosarcoma - Planning

EXAMINER

"A 16-year-old male presents with a 3-month history of progressive right knee pain. X-rays show a destructive lesion in the distal femur with periosteal reaction. MRI confirms a 10cm lesion extending to within 4cm of the joint line with soft tissue mass but no joint involvement. Chest CT is clear. Biopsy confirms high-grade osteosarcoma."

EXCEPTIONAL ANSWER
**Opening Statement:** "This is a high-grade osteosarcoma of the distal femur in an adolescent male. Based on the imaging, this is Enneking Stage IIB - high-grade, extracompartmental with soft tissue extension, no metastases detected." **Staging Summary:** - Grade: High (G2) - biopsy confirmed - Site: Extracompartmental (T2) - soft tissue mass - Metastases: None detected (M0) - clear chest CT - Therefore Stage IIB **Treatment Plan:** "I would present this case at our sarcoma MDT. The standard treatment for high-grade osteosarcoma is: 1. **Neoadjuvant chemotherapy**: MAP protocol (methotrexate, adriamycin, cisplatin) for 10-12 weeks 2. **Restaging MRI**: Assess response, confirm resection margins 3. **Limb salvage surgery**: Wide resection with endoprosthetic reconstruction 4. **Adjuvant chemotherapy**: Continue post-operatively based on histological response" **Surgical Planning:** "For the resection, I would plan a bone cut at least 2cm proximal to the MRI-defined tumour extent - so at least 12cm from the joint line. Given the tumour extends to 4cm from joint, I cannot preserve the joint. I would perform wide resection including a cuff of normal muscle around the soft tissue mass, and reconstruct with a modular distal femoral replacement prosthesis." **Key Considerations:** "I would counsel the patient and family about: - Expected 65-70% survival at 5 years with current protocols - 70-80% prosthesis survival at 10 years - Need for multiple revisions likely over lifetime - Alternative of amputation provides equivalent survival"
KEY POINTS TO SCORE
Enneking staging: IIB (high-grade, extracompartmental, no mets)
Neoadjuvant chemotherapy is standard for osteosarcoma
Wide margin = 2cm bone + cuff of normal tissue
Endoprosthesis is standard reconstruction for distal femur
COMMON TRAPS
✗Proceeding to surgery without neoadjuvant chemotherapy
✗Planning inadequate bone margin (less than 2cm from tumour)
✗Not mentioning MDT discussion
✗Forgetting to discuss alternatives including amputation
LIKELY FOLLOW-UPS
"What if the tumour extended to within 1cm of the joint - how would this change your plan?"
"What are the complications of distal femoral endoprosthesis?"
"How would you manage if there was a skip lesion in the proximal femur?"
"What is the role of rotationplasty in this patient?"
VIVA SCENARIOChallenging

Proximal Tibia Tumour in Child

EXAMINER

"An 8-year-old girl has been diagnosed with osteosarcoma of the proximal tibia. She has completed neoadjuvant chemotherapy with good response. MRI shows the tumour 3cm from the joint with good response to chemotherapy. Chest CT is clear."

EXCEPTIONAL ANSWER
**Opening Statement:** "This is a challenging case of proximal tibia osteosarcoma in a skeletally immature patient. The key issues are achieving oncological margins while addressing significant expected limb length discrepancy and extensor mechanism reconstruction." **Reconstruction Options:** **1. Expandable Endoprosthesis:** "A growing proximal tibia replacement would allow limb salvage with staged lengthening. Advantages: - Immediate stability and function - Preserves limb length equality with lengthening Challenges: - 15-20 lengthening procedures until skeletal maturity - 50-70% complication rate during childhood - Extensor mechanism reattachment has high failure rate (10-20%) - Infection risk 10-15%" **2. Rotationplasty:** "Van Nes rotationplasty resects the tumour segment and rotates the distal limb 180 degrees. The ankle becomes a functional knee joint. Advantages: - Single definitive procedure - No implant-related complications - Excellent functional outcomes (MSTS 80-90%) - Growth potential preserved - Superior to above-knee amputation functionally Challenges: - Cosmetic appearance of reversed foot - Psychological adjustment required - Requires highly motivated family" **3. Above-Knee Amputation:** "Transfemoral amputation is a reliable option with predictable outcomes. Advantages: - Single procedure, no implant complications - Modern prosthetics allow good function Challenges: - Loss of biological knee - Higher energy expenditure for ambulation - Phantom limb issues" **My Recommendation:** "I would discuss all three options with the family in detail. For an 8-year-old facing 10 years of growth, I would particularly highlight rotationplasty as an option that provides excellent function with a single procedure. The decision ultimately depends on family preferences after thorough counselling."
KEY POINTS TO SCORE
Growing prosthesis allows limb length management but has high complication burden
Rotationplasty offers excellent function with single procedure
Proximal tibia has challenging extensor mechanism issues
Present all options - family decision after informed consent
COMMON TRAPS
✗Only discussing endoprosthesis without alternatives
✗Underestimating complications of growing prosthesis
✗Dismissing rotationplasty without fair discussion
✗Not considering limb length discrepancy over 10 years of growth
LIKELY FOLLOW-UPS
"How would you manage extensor mechanism reconstruction?"
"What is the expected limb length discrepancy without intervention?"
"How does a non-invasive expanding prosthesis work?"
"What are the psychological outcomes after rotationplasty?"
VIVA SCENARIOChallenging

Infected Tumour Prosthesis

EXAMINER

"A 25-year-old woman had a distal femoral replacement for osteosarcoma 3 years ago. She presents with a 6-week history of increasing knee pain, swelling, and a discharging sinus. Inflammatory markers are elevated. Aspiration grows Staphylococcus aureus."

EXCEPTIONAL ANSWER
**Opening Statement:** "This patient has a chronic periprosthetic joint infection of a tumour endoprosthesis, classified as Henderson Type 4 failure. This is a serious complication with significant implications for limb survival." **Initial Assessment:** "I would: 1. Confirm infection with repeat aspiration if needed 2. Stage with CT chest - ensure no disease recurrence 3. Assess local soft tissue and bone stock 4. Review oncological history - margin status, adjuvant treatment 5. MDT discussion including orthopaedic oncology, infectious diseases, plastic surgery" **Management Options:** **1. Two-Stage Revision:** "This is my preferred approach for chronic infection with biofilm. Stage 1: - Remove all prosthetic components and cement - Radical debridement of infected tissue - Insert antibiotic-loaded cement spacer - 6 weeks IV antibiotics, then oral suppression Stage 2 (after 3-6 months, infection controlled): - Remove spacer - Reimplant new endoprosthesis - Consider augmentation with flap if soft tissue deficient" **2. DAIR (Debridement, Antibiotics, Implant Retention):** "Only appropriate for early infection (under 3 weeks) with stable implant. Not appropriate here with 6-week history and sinus - biofilm established." **3. Amputation:** "May be necessary if: - Two-stage revision fails - Uncontrollable sepsis - Poor bone stock precludes reconstruction - Patient preference - Life-threatening systemic sepsis" **Key Considerations:** "Success rate for two-stage revision in tumour prosthesis is 60-70% - lower than primary arthroplasty infection. Amputation required in 20-30% of infected tumour prostheses. I would counsel the patient that while we will attempt limb salvage, amputation may ultimately be necessary if infection cannot be controlled." **Practical Steps:** - Involve infectious diseases from outset - Culture-directed antibiotics (Staph aureus - flucloxacillin or vancomycin if MRSA) - Plastic surgery review for soft tissue coverage - Consider muscle flap at reimplantation - Prolonged antibiotic course post-reimplantation
KEY POINTS TO SCORE
Chronic infection with sinus = biofilm established, DAIR not appropriate
Two-stage revision is standard for chronic PJI in tumour prosthesis
Success rate 60-70% - lower than primary arthroplasty
Amputation may be required in 20-30% - counsel patient
COMMON TRAPS
✗Attempting DAIR for chronic infection (will fail)
✗Not involving MDT and infectious diseases
✗Underestimating risk of amputation
✗Forgetting to exclude tumour recurrence
LIKELY FOLLOW-UPS
"What antibiotic would you use in the cement spacer?"
"How would you manage soft tissue coverage at reimplantation?"
"What if cultures show MRSA?"
"When would you proceed directly to amputation?"

Australian Context

Epidemiology and Referral Patterns

Primary bone sarcomas are rare in Australia, with approximately 200 new cases of bone sarcoma diagnosed annually. Osteosarcoma accounts for approximately 35% of cases, with peak incidence in adolescents and young adults. Given the rarity and complexity of these tumours, management is concentrated in specialized sarcoma centres in major metropolitan areas.

The Australian Sarcoma Group and state-based sarcoma services coordinate multidisciplinary care. Patients in regional and remote areas face significant travel burdens for treatment at tertiary centres, highlighting the importance of telehealth consultation and shared care arrangements with local oncology units where appropriate.

Treatment Protocols and Access

Australian treatment protocols for osteosarcoma generally follow international standards with neoadjuvant chemotherapy (MAP protocol) followed by wide resection and adjuvant chemotherapy. The Pharmaceutical Benefits Scheme (PBS) provides subsidized access to chemotherapy agents including methotrexate, doxorubicin, and cisplatin. Modern modular endoprosthetic systems are available through orthopaedic oncology units, with custom prostheses manufactured locally or imported.

Growing prostheses present particular challenges in the Australian context due to the need for repeated procedures over many years. Families in regional areas face substantial logistical challenges, making rotationplasty an attractive option in appropriate cases. Prosthetic services for rotationplasty patients and amputees are provided through state-based limb services and private prosthetists, with funding available through various schemes including the National Disability Insurance Scheme (NDIS) for eligible patients.

AOANJRR Considerations

While the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) primarily focuses on primary and revision arthroplasty, tumour prostheses represent a distinct subset with different expected outcomes. The higher complication and revision rates for oncological reconstruction must be understood in context - these are salvage procedures in often young patients facing life-threatening disease, where the alternative is amputation. Surgeons should maintain their own data on tumour prosthesis outcomes and participate in international registries where available.

Limb Salvage Surgery Principles

High-Yield Exam Summary

Enneking Staging

  • •Stage I = Low grade (IA intracompartmental, IB extracompartmental)
  • •Stage II = High grade (IIA intracompartmental, IIB extracompartmental)
  • •Stage III = Any grade with metastases
  • •Benign: 1 latent, 2 active, 3 aggressive

Surgical Margins

  • •Intralesional = through tumour (contamination) - 90% recurrence
  • •Marginal = through reactive zone - 50% microscopic disease
  • •Wide = through normal tissue cuff - MINIMUM for sarcoma
  • •Radical = entire compartment - rarely performed now
  • •Wide margin: 2cm bone + cuff of normal tissue

Reconstruction Options

  • •Endoprosthesis = workhorse for periarticular tumours (70-80% 10-yr survival)
  • •Allograft = biological but high complication (nonunion 20%, fracture 20%)
  • •APC = allograft-prosthesis composite (soft tissue attachment + joint)
  • •Vascularized fibula = intercalary defects, paediatric
  • •Growing prosthesis = paediatric, 15-20 lengthenings needed
  • •Rotationplasty = excellent function, single procedure, cosmetic concerns

Key Numbers

  • •Limb salvage rate: 85-90% for bone sarcoma
  • •Survival equivalent to amputation if margins adequate
  • •Endoprosthesis infection: 10-15% (vs 1-2% primary TKR)
  • •10-year prosthesis survival: 70-80%
  • •30% reoperation rate at 10 years (any cause)
  • •Growing prosthesis complication rate: 50-70% during childhood

Henderson Classification

  • •Type 1 = Soft tissue (1A wound, 1B instability/tendon)
  • •Type 2 = Aseptic loosening
  • •Type 3 = Structural (3A periprosthetic fracture, 3B implant fracture)
  • •Type 4 = Infection
  • •Type 5 = Tumour progression

Exam Day Essentials

  • •Whole bone MRI essential - skip metastases in 1-5%
  • •Biopsy track must be excised with specimen
  • •MDT essential for all sarcomas
  • •Neoadjuvant chemo standard for osteosarcoma
  • •Rotationplasty underutilized - excellent function in children
  • •Amputation is NOT failure if margins cannot be achieved

References

  1. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 1980;(153):106-120.

  2. Rougraff BT, Simon MA, Kneisl JS, et al. Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study. J Bone Joint Surg Am. 1994;76(5):649-656.

  3. Jeys LM, Kulber A, Grimer RJ, et al. Endoprosthetic reconstruction for the treatment of musculoskeletal tumors of the appendicular skeleton and pelvis. J Bone Joint Surg Am. 2008;90(6):1265-1271.

  4. Henderson ER, Groundland JS, Pala E, et al. Failure mode classification for tumor endoprostheses: retrospective review of five institutions and a literature review. J Bone Joint Surg Am. 2011;93(5):418-429.

  5. Hillmann A, Rosenbaum D, Schröter J, et al. Electromyographic and gait analysis of forty-three patients after rotationplasty. J Bone Joint Surg Am. 2000;82(2):187-196.

  6. Groundland JS, Binitie O. Reconstruction after tumor resection in the growing child. Orthop Clin North Am. 2016;47(1):265-281.

  7. Grimer RJ, Aydin BK, Wafa H, et al. Very long-term outcomes after endoprosthetic replacement for malignant tumours of bone. Bone Joint J. 2016;98-B(6):857-864.

  8. Mavrogenis AF, Ruggieri P, Mercuri M, et al. Allograft-prosthesis composite for reconstruction of proximal femur bone tumors. Orthopedics. 2010;33(12):888.

  9. Benevenia J, Kirchner R, Patterson F, et al. Outcomes of a modular intercalary endoprosthesis as treatment for segmental defects of the femur, tibia, and humerus. Clin Orthop Relat Res. 2016;474(2):539-548.

  10. Gosheger G, Gebert C, Ahrens H, et al. Endoprosthetic reconstruction in 250 patients with sarcoma. Clin Orthop Relat Res. 2006;450:164-171.

Quick Stats
Reading Time121 min
Related Topics

Adamantinoma

Aneurysmal Bone Cyst

Angiosarcoma

Biopsy Principles and Techniques in Orthopaedic Oncology